良性前列腺增生的微创治疗:一项Cochrane网状Meta分析
该Cochrane网状Meta分析纳入27项随机对照试验共3017例男性,比较WVTT、PAE、PUL、TIND、TUMT与TURP或假手术对BPH相关LUTS的疗效。多数结局证据确定性为低至极低;短期随访下,PUL和PAE在泌尿症状上可能不劣于TURP,而WVTT、TUMT和TIND可能更差;微创治疗可能大幅减少主要不良事件。
要点
- 与TURP相比,PUL和PAE对泌尿症状可能无差异,WVTT、TUMT和TIND可能更差。
- 微创治疗相比TURP可能大幅减少主要不良事件。
- TUMT再治疗率可能更高;PUL和PAE的再治疗效应不确定。
核心结论
- 短期随访下,微创治疗在泌尿症状和生活质量上相比TURP可能效果相似或更差。
研究设计与样本
- Cochrane网状Meta分析,检索多个数据库至2021年2月24日。
- 纳入27项随机对照试验,共3017例男性。
- 比较WVTT、PAE、PUL、TIND、TUMT与TURP或假手术。
- 采用频率学派网状Meta分析,GRADE评估证据确定性。
主要发现
- 与TURP相比,PUL和PAE对泌尿症状可能几乎无差异,WVTT、TUMT和TIND可能症状更差。
- 与TURP相比,微创治疗对生活质量可能几乎无差异。
- 与TURP相比,微创治疗可能大幅减少主要不良事件。
- PAE和PUL对再治疗的影响不确定,TUMT可能再治疗率更高。
- 微创治疗对勃起功能和射精功能的影响极不确定。
关键数值与推荐
- 多数结局的GRADE证据确定性为低至极低。
- 在微创治疗中,PUL和PAE对泌尿症状和生活质量最有效的可能性最高。
- TUMT对主要不良事件最有效的可能性最高。
- WVTT和TIND对勃起功能最有效的可能性最高,PUL对射精功能最有效的可能性最高。
- 排除仅有3个月短期随访的WVTT和TIND后,PUL对再治疗最有效的可能性最高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数结局的GRADE证据确定性为低至极低。
- 对PAE和PUL的再治疗效应不确定,对微创治疗的勃起和射精功能效应极不确定。
- WVTT和TIND仅有短期(3个月)随访研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the comparative effectiveness and ranking of minimally invasive treatments (MITs) for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We searched multiple databases up to 24 February 2021. We included randomized controlled trials assessing the following treatments: convective radiofrequency water vapour thermal therapy (WVTT; or Rezūm); prostatic arterial embolization (PAE); prostatic urethral lift (PUL; or Urolift); temporary implantable nitinol device (TIND); and transurethral microwave thermotherapy (TUMT) compared to transurethral resection of the prostate (TURP) or sham surgery. We performed a frequentist network meta-analysis. RESULTS: We included 27 trials involving 3017 men. The overall certainty of the evidence of most outcomes according to GRADE was low to very low. Compared to TURP, we found that PUL and PAE may result in little to no difference in urological symptoms, while WVTT, TUMT and TIND may result in worse urological symptoms. MITs may result in little to no difference in quality of life, compared to TURP. MITs may result in a large reduction in major adverse events compared to TURP. We were uncertain about the effects of PAE and PUL on retreatment compared to TURP, however, TUMT may result in higher retreatment rates. We were very uncertain of the effects of MITs on erectile function and ejaculatory function. Among MITs, PUL and PAE had the highest likelihood of being the most efficacious for urinary symptoms and quality of life, TUMT for major adverse events, WVTT and TIND for erectile function and PUL for ejaculatory function. Excluding WVTT and TIND, for which there were only studies with short-term (3-month) follow-up, PUL had the highest likelihood of being the most efficacious for retreatment. CONCLUSIONS: Minimally invasive treatments may result in similar or worse effects concerning urinary symptoms and quality of life compared to TURP at short-term follow-up.
引用
- Franco JVA, Jung JH, Imamura M, et al. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis. BJU Int. 2021. PMID: 34820997. doi:10.1111/bju.15653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。